Article ID Journal Published Year Pages File Type
5698768 Clinical Oncology 2013 7 Pages PDF
Abstract
The addition of docetaxel to a cisplatin doublet ICT regimen before concurrent CRT may improve disease control for locally advanced HNSCC.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , , , ,